1. Anlotinib, a novel TKI, as a third-line or further-line treatment in patients with advanced non-small cell lung cancer in China: A systemic review and meta-analysis of its efficacy and safety. Issue 23 (11th June 2021) Authors: Ye, Haiyong; Li, Zhaoyi; Liu, Kangning; Zhang, Feng; Cheng, Zhengliang Other Names: Ding. Jianxun section editor. Journal: Medicine Issue: Volume 100:Issue 23(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cellulose nanofibers prepared from TEMPO‐oxidation of kraft pulp and its flocculation effect on kaolin clay. Issue 12 (29th January 2014) Authors: Jin, Liqiang; Wei, Yanwei; Xu, Qinghua; Yao, Wenrun; Cheng, Zhengliang Journal: Journal of applied polymer science Issue: Volume 131:Issue 12(2014:Jun. 15) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗